Suppr超能文献

[噻吩二氮䓬类新型抗焦虑药物氯噻西泮(Trecalmo)的治疗经验。186例患者的现场研究结果]

[Therapeutic experiences with clotiazepam (Trecalmo), a new anxiolytic drug from the thienodiazepine group. Results of a field study on 186 patients].

作者信息

Sieberns S

出版信息

Fortschr Med. 1979 Oct 11;97(38):1705-8.

PMID:41803
Abstract

The efficacy and the compatibility of the new anxiolytic Trecalmo (Clotiazepam) were investigated by means of a field trial covering 186 patients, suffering from anxiety and tension as well as from psychosomatic disorders. The new drug proved to be remarkably effective in symptoms as anxiety, restlessness, irritations, tension headache as well as functional cardiovascular diseases and digestive disorders. The compatibility was good.

摘要

通过一项涵盖186名患有焦虑、紧张以及身心疾病患者的现场试验,对新型抗焦虑药曲卡莫(氯噻西泮)的疗效和耐受性进行了研究。结果表明,这种新药对焦虑、烦躁、易怒、紧张性头痛以及功能性心血管疾病和消化系统疾病等症状具有显著疗效,耐受性良好。

相似文献

8
Autonomic perception and responses in anxiety-inducing situations.在引发焦虑的情境中的自主感知与反应。
Pharmakopsychiatr Neuropsychopharmakol. 1978 May;11(3):113-20. doi: 10.1055/s-0028-1094569.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验